Most #GLP-1 Medications Correlated with a Lower Likelihood of #Anxiety and #Depression Diagnoses

Posted on by aledopress

Key Findings

Diabetic patients prescribed tirzepatide, semaglutide, dulaglutide, and exenatide are less likely to be diagnosed with depression after starting the medication compared to those not on a glucagon-like peptide-1 receptor agonist (GLP-1) medication.  

The likelihood of anxiety in diabetic patients is lower for those on all five GLP-1 medications studied. 

Among non-diabetic patients, semaglutide is correlated with a lower likelihood of depression and anxiety, while liraglutide showed no statistically significant difference compared to those on non-GLP-1 weight management medications. 

https://www.epicresearch.org/articles/most-glp-1-medications-correlated-with-a-lower-likelihood-of-anxiety-and-depression-diagnoses